This site contains affiliate links. We may earn a commission at no extra cost to you. Disclosure
Performance

The GLP-1 + Creatine Stack: What We Know (and Don't) About Muscle Preservation

·9 min read

The Bottom Line

GLP-1 medications cause real muscle loss — 15–40% of total weight lost can come from lean tissue. The BELIEVE trial proved that pharmaceutical solutions exist (92.8% fat loss when combining semaglutide with bimagrumab), but those aren't available yet. What you can do right now: resistance training, 1.2–1.5g protein per kg daily, and creatine monohydrate. No trial has directly studied creatine + GLP-1, but the mechanistic case for creatine as a muscle-preservation supplement during GLP-1 therapy is strong. Here's the evidence.

The Muscle Loss Problem Is Real

This isn't a theoretical concern. When you lose weight on any intervention — GLP-1s, bariatric surgery, dieting — some of that weight comes from lean mass (muscle, bone, connective tissue). With GLP-1 medications specifically, the ratio is concerning:

Drug / TrialTotal Weight Loss% from Lean Mass
Semaglutide 2.4mg (STEP 1)14.9%~39%
Tirzepatide (SURMOUNT)20.9%33–38%
Pemvidutide (MOMENTUM Phase 2)21.9%
Semaglutide + Bimagrumab (BELIEVE)22.1%7.2%

For a man who loses 40 pounds on semaglutide, roughly 15 pounds of that could be muscle — an amount that meaningfully reduces strength, metabolic rate, and functional capacity. For men over 40, who are already losing muscle at 3–8% per decade from sarcopenia, this accelerates a process that directly affects quality of life.

92.8%
of total weight loss was from fat mass when bimagrumab was combined with semaglutide in the BELIEVE trial — proving pharmaceutical muscle preservation is possible
Source: BELIEVE Phase 2b Trial, published JAMA 2025, presented ADA 85th Scientific Sessions

The BELIEVE Trial Changed the Conversation

The BELIEVE Phase 2b trial (507 participants, published in JAMA 2025) tested bimagrumab — a monoclonal antibody that targets activin type II receptors, promoting muscle preservation and growth — combined with semaglutide 2.4mg. The combination achieved 22.1% total body weight loss, with an unprecedented 92.8% of that loss coming from fat mass.

For context: in the semaglutide-alone group, only 71.8% of weight loss came from fat. The combination dramatically shifted the composition of weight loss from "losing everything, including muscle" to "losing almost exclusively fat."

The problem: bimagrumab is an IV infusion administered every 12 weeks and isn't commercially available yet. It's a proof of concept, not something you can get from your telehealth provider. But it proves that the muscle loss problem is solvable — the question is what men can do right now while the pharmaceutical solutions work through development.

The Case for Creatine During GLP-1 Therapy

No published clinical trial has studied creatine supplementation specifically in patients taking GLP-1 medications. We need to be honest about that. But the mechanistic rationale for adding creatine during GLP-1 therapy is strong enough to merit serious consideration.

What creatine does that matters here

Increases intracellular water retention in muscle cells. This creates a hydration-driven anabolic signal that promotes protein synthesis. During a caloric deficit (which GLP-1s create through appetite suppression), this anti-catabolic effect is especially valuable.

Enhances high-intensity exercise capacity. Creatine phosphate is the primary energy substrate for short-duration, high-intensity efforts — exactly the type of resistance training recommended for muscle preservation during GLP-1 therapy. If you can lift heavier, you send a stronger muscle-preservation signal.

May directly support lean mass retention during caloric restriction. Multiple studies in non-GLP-1 populations have shown that creatine supplementation during caloric restriction preserves more lean mass than restriction alone, particularly when combined with resistance training.

Has a decades-long safety profile. Creatine monohydrate is the single most studied sports supplement in history. The International Society of Sports Nutrition has confirmed its safety for long-term use. There are no known interactions with GLP-1 receptor agonist medications.

What creatine does NOT do: Creatine is not bimagrumab. It won't transform your weight loss composition from 60% fat/40% lean to 93% fat/7% lean. It's one tool in a larger preservation strategy. The three-legged stool is resistance training + adequate protein + supplemental support. Creatine strengthens one leg. All three need to be standing.

The Practical Protocol

Based on current evidence from exercise physiology, nutrition research, and GLP-1 clinical data, here's a framework for men looking to preserve muscle during GLP-1 therapy:

1. Resistance training — the non-negotiable

This is the single most important intervention. Resistance training sends the direct biological signal that your body needs its muscle tissue. Without this signal, your body treats muscle as expendable during a caloric deficit. Train 3–4 days per week with progressive overload. Compound movements (squat, deadlift, bench, row, overhead press) are more efficient than isolation exercises for this purpose. If you're not currently lifting, start with a basic strength program — even bodyweight movements at home are better than nothing.

2. Protein — the minimum effective dose

Current guidelines for GLP-1 patients recommend 1.2–1.5 grams of protein per kilogram of ideal body weight daily. For a man targeting 185 lbs (84 kg), that's 100–126 grams of protein per day. This is challenging on GLP-1s because appetite suppression makes it hard to eat enough — which is exactly why protein needs to be prioritized at every meal. Protein shakes, Greek yogurt, and lean meat become strategic tools, not optional add-ons.

3. Creatine monohydrate — the supplemental support

5 grams of creatine monohydrate daily. No loading phase needed — the research shows that daily supplementation of 3–5 grams reaches saturation within 3–4 weeks. Take it at any time, with or without food. Creatine monohydrate (not HCl, not ethyl ester, not any of the fancy branded versions) remains the most studied and most effective form.

4. The rest of the stack — what actually matters

Beyond creatine, a few other supplements have evidence for lean mass preservation during caloric restriction: vitamin D (most men are deficient, and deficiency is associated with muscle loss), omega-3 fatty acids (anti-inflammatory, may support protein synthesis), and branched-chain amino acids or essential amino acids (though these matter less if protein intake is already adequate).

What We're Still Waiting For

The research pipeline is moving fast. The BICEP study (NCT07226947) at Massachusetts General Hospital is recruiting right now — it's testing whether smartwatch-based activity monitoring and exercise guidance can improve muscle mass outcomes in patients starting GLP-1 therapy. A separate 2-year clinical trial (NCT07091500) is specifically evaluating body composition and muscle function in response to GLP-1 therapy with and without exercise training.

What we really need — and what doesn't exist yet — is a randomized controlled trial specifically testing creatine + resistance training + GLP-1 vs. resistance training + GLP-1 alone. Given the safety profile of creatine and the plausible mechanism, this seems like low-hanging research fruit. Until that data exists, the recommendation to supplement creatine is based on extrapolation from resistance training populations, not direct GLP-1 evidence.

For men who are already training and supplementing creatine: keep doing it. There's no reason to stop when starting a GLP-1. For men starting GLP-1s who don't currently resistance train: this is the moment to start. The muscle you preserve now is dramatically easier to keep than muscle you try to rebuild later.

SHED

Comprehensive GLP-1 program with multiple medication formats. Starting at $297–$299/mo.

Get Started →

Care Bare Rx

Compounded GLP-1 with intake consultation. From $199/month.

Get Started →

Start Your GLP-1 Journey With a Plan

Weight loss without muscle loss requires the right provider, the right protocol, and the right support. Compare providers that take body composition seriously.

SHED — Multi-Format Options Care Bare — From $199/mo

Paid links · Compounded medications are not FDA-approved · Pricing verified April 2026

Sources

  1. BELIEVE Phase 2b Trial. "Bimagrumab + Semaglutide." Published JAMA 2025, presented ADA 85th Scientific Sessions. ADA
  2. Wilding, J.P.H. et al. STEP 1 Trial. "Once-weekly semaglutide in adults with overweight or obesity." NEJM, 2021.
  3. Pennington Biomedical Research Center. "BELIEVE spotlights quality and quantity approach to weight management." PBRC
  4. International Society of Sports Nutrition. Position stand on creatine supplementation and exercise. JISSN, 2017.
  5. BICEP Study. ClinicalTrials.gov. NCT07226947